DS

Dirk Sauer

Independent Chair of the Board

PulseSight Therapeutics

PulseSight Therapeutics Pipeline

DrugIndicationPhase
PST-611Dry AMD / Geographic AtrophyPhase 1
PST-809Wet AMDPhase 1/2